Latest Celebrex news
No Benefit Seen From Adjuvant Celecoxib in ERBB2-Negative Breast Cancer
posted July 16th
by modernClinician Editorial Team
by modernClinician Editorial Team
No Benefit Seen From Adjuvant Celecoxib in ERBB2-Negative Breast Cancer
posted July 16th
by modernClinician Editorial Team
by modernClinician Editorial Team
ACR: Chondroitin Sulfate Cuts Cartilage Volume Loss in Knee OA
posted November 10th
by modernClinician Editorial Team
by modernClinician Editorial Team
For patients with knee osteoarthritis, chondroitin sulfate is associated with additional benefits in terms of cartilage volume loss compared with celecoxib, according to a study presented at the annual meeting of the American College of Rheumatology, held from Nov. 6 to 11 in San Francisco.
Review Reveals Limited Effects of Exercise on Hip Osteoarthritis
Oral Microbiome Dysbiosis Linked to Symptomatic Hand Osteoarthritis
Long-Term Outcomes Favor Patellar Resurfacing During Total Knee Replacement
Nonsurgical Procedure Tied to Improved Osteoarthritis-Related Knee Pain
Botox Helpful in Alleviating Chronic Migraine in Pediatric Patients
Platelet-Rich Plasma, Shockwave Therapy Show Therapeutic Efficacy in Interstitial Cystitis
Data Reveal No Hypersensitivity Due to Axillary Brachial Plexus Block Alone
Adding Cognitive Behavioral Therapy, Self-Management Does Not Improve Opioid Taper Success